ArticleClinicoEconomics and outcomes research : CEOR2019
Social Return On Investment For Patient Treated By Continuous Ambulatory Peritoneal Dialysis: A Case Study In Ubon Ratchathani Province, Thailand.
Article in ClinicoEconomics and outcomes research : CEOR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 6 citations in OpenAlex.
- The impact of improving haemophilia A management within the Spanish National Healthcare System: a social return on investment analysis.BMC health services research · 2022Article
- Social value of a set of proposals for the ideal approach of multiple sclerosis within the Spanish National Health System: a social return on investment study.BMC health services research · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeIn Thailand, continuous ambulatory peritoneal dialysis (CAPD) has become the first option for renal replacement therapy (RRT) under the universal health coverage scheme (UCS) for more than a decade. However, there is limited evidence to demonstrate the social value of this policy. Hence, this study aims to evaluate the social return on investment (SROI) of end-stage renal disease (ESRD) patients treated by CAPD modality under UCS in Ubon Ratchathani province, Thailand. PATIENTS AND
methodsThis study follows six steps of SROI principle and framework. It is a mixed method of exploratory sequential design divided into 2 parts; the first part is qualitative research using content analytics to ascertain find out what is the cost in societal view and social value outcome. Then in the second part, take it information gathered from the first part was used to create a research tool to quantitatively collect the data from 191 informants. The data has been analyzed to calculate SROI ratio and interpret the amount of social value created per 1 Thai Baht (THB) of investment.
resultsThe key social value outcomes are; CAPD patients have a good quality of life, not being a burden on society and willing to undergo kidney transplantation in the future. The costs in societal view are direct medical costs reimbursement from the national health security office (NHSO), direct non-medical costs, and indirect costs are CAPD patients' out-of-pocket expense. The proportion of the costs from NHSO and the patient is 81:19. The SROI ratio is 1.60:1. It means that 1 THB on investment can generate the social value of 1.60 THB.
conclusionThe investment for ESRD patient treated by CAPD modality is worth social value benefits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.